-
EP1092434
European procedure
Extract from the Register of European Patents
EP About this file: EP1092434
| EP1092434 - Novel composition containing lansoprazole and process for its preparation [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.01.2005 Database last updated on 19.10.2024 | Most recent event Tooltip | 28.01.2005 | No opposition filed within time limit | published on 16.03.2005 [2005/11] | Applicant(s) | For all designated states Pharma Pass II LLC Suite I-108, 15375 Barranca Parkway Irvine, CA 92618 / US | [N/P] |
| Former [2003/06] | For all designated states Pharma Pass II LLC Suite I-108, 15375 Barranca Parkway Irvine, CA 92618 / US | ||
| Former [2001/16] | For all designated states Pharma Pass LLC Suite I-108, 15375 Barranca Parkway Irvine, CA 92718 / US | Inventor(s) | 01 /
Seth, Pawan 10 Meryton Irvine, CA 92612 / US | [2001/16] | Representative(s) | Best, Michael Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | [N/P] |
| Former [2005/05] | Best, Michael, Dr. Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE | ||
| Former [2001/16] | Cabinet Hirsch 34, Rue de Bassano 75008 Paris / FR | Application number, filing date | 00127495.0 | 23.09.1996 | [2001/16] | Priority number, date | FR19950011094 | 21.09.1995 Original published format: FR 9511094 | FR19950014492 | 07.12.1995 Original published format: FR 9514492 | FR19960002265 | 23.02.1996 Original published format: FR 9602265 | FR19960005082 | 23.04.1996 Original published format: FR 9605082 | [2001/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1092434 | Date: | 18.04.2001 | Language: | EN | [2001/16] | Type: | B1 Patent specification | No.: | EP1092434 | Date: | 24.03.2004 | Language: | EN | [2004/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.02.2001 | Classification | IPC: | A61K31/4439, A61K31/4184, A61K9/30 | [2003/37] | CPC: |
A61K9/5073 (EP,US);
A61K31/4184 (EP,US);
A61K31/4439 (EP,US);
A61K9/2886 (EP,US);
A61K9/4808 (EP,US);
A61K9/5078 (EP,US);
A61P1/04 (EP)
(-)
|
| Former IPC [2001/16] | A61K31/4439, A61K31/4184 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/16] | Title | German: | Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren | [2001/16] | English: | Novel composition containing lansoprazole and process for its preparation | [2001/16] | French: | Composition de lansoprazole et procédé de préparation | [2001/16] | Examination procedure | 29.09.2001 | Examination requested [2001/48] | 26.07.2002 | Despatch of a communication from the examining division (Time limit: M04) | 25.11.2002 | Reply to a communication from the examining division | 01.09.2003 | Communication of intention to grant the patent | 12.01.2004 | Fee for grant paid | 12.01.2004 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP96931210.7 / EP0854718 | Opposition(s) | 28.12.2004 | No opposition filed within time limit [2005/11] | Fees paid | Renewal fee | 17.04.2001 | Renewal fee patent year 03 | 17.04.2001 | Renewal fee patent year 04 | 17.04.2001 | Renewal fee patent year 05 | 27.09.2001 | Renewal fee patent year 06 | 30.09.2002 | Renewal fee patent year 07 | 25.09.2003 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]EP0519365 (BYK GULDEN LOMBERG CHEM FAB [DE]) [YD] 1-14 * claims 1-3 * * page 3, line 1 - line 9 * * example 2 *; | [YD]EP0519144 (ILSAN ILAC VE HAMMADDELERI SAN [TR]) [YD] 1-14 * claim - * * page 2, line 33 - page 3, line 26 *; | [YD]WO9325204 (ETHYPHARM SA [ES], et al) [YD] 1-14 * claim - * * page 3, line 27 - line 30 * * example 1 * * page 14, line 20 - line 24 *; | [PDX]WO9601624 (ASTRA AB [SE], et al) [PDX] 1-14 * claim - * * examples 1,7 * * page 11, line 3 - line 6 * * page 3, line 28 - line 30 * * page 13, line 18 - line 25 ** page 14, line 17 - line 26 * |